| Publication type: | Conference other |
| Type of review: | Peer review (abstract) |
| Title: | Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC) |
| Authors: | Dürr, Oliver Franzini, Anca Brutsche, Martin Baty, Florent |
| Published in: | The European Respiratory Journal |
| Volume(Issue): | 44 |
| Issue: | Suppl 58 |
| Conference details: | 22nd Annual Congress of the European Respiratory Society, Munich, Germany, 6-10 September 2014 |
| Issue Date: | 2014 |
| Publisher / Ed. Institution: | European Respiratory Society |
| ISSN: | 0904-1850 |
| Language: | English |
| Subject (DDC): | 572: Biochemistry 616: Internal medicine and diseases |
| Further description: | Abstract |
| URI: | https://digitalcollection.zhaw.ch/handle/11475/13893 |
| Fulltext version: | Published version |
| License (according to publishing contract): | Licence according to publishing contract |
| Departement: | School of Engineering |
| Organisational Unit: | Institute of Data Analysis and Process Design (IDP) |
| Appears in collections: | Publikationen School of Engineering |
Files in This Item:
There are no files associated with this item.
Show full item record
Dürr, O., Franzini, A., Brutsche, M., & Baty, F. (2014). Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC) [Conference presentation]. The European Respiratory Journal, 44(Suppl 58).
Dürr, O. et al. (2014) ‘Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC)’, in The European Respiratory Journal. European Respiratory Society.
O. Dürr, A. Franzini, M. Brutsche, and F. Baty, “Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC),” in The European Respiratory Journal, 2014, vol. 44, no. Suppl 58.
DÜRR, Oliver, Anca FRANZINI, Martin BRUTSCHE und Florent BATY, 2014. Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC). In: The European Respiratory Journal. Conference presentation. European Respiratory Society. 2014
Dürr, Oliver, Anca Franzini, Martin Brutsche, and Florent Baty. 2014. “Tumor-Associated Stromal Gene Expression Signatures Predict Therapeutic Response to Erlotinib/Bevacizumab in Non-Small Cell Lung Cancer (NSCLC).” Conference presentation. In The European Respiratory Journal. Vol. 44. European Respiratory Society.
Dürr, Oliver, et al. “Tumor-Associated Stromal Gene Expression Signatures Predict Therapeutic Response to Erlotinib/Bevacizumab in Non-Small Cell Lung Cancer (NSCLC).” The European Respiratory Journal, vol. 44, no. Suppl 58, European Respiratory Society, 2014.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.